ChemDiv to Supply Italien Nerviano Medical Sciences with Discovery Chemical Libraries
Advertisement
ChemDiv, Inc. and Nerviano Medical Sciences (NervianoMS), Milano, Italy, announced an extension of their collaboration to an additional 2 year program. NervianoMS will use services of ChemDiv for building and enriching its portfolio of proprietary discovery chemical libraries. Such compound libraries are instrumental in enhancing the access to novel bioactive compounds. This agreement capitalizes on ChemDiv´s success in contributing its world largest small molecule collection and library designs set to NervianoMS discovery chemistry assets, as well as strengths and experience in managing global medicinal and synthetic chemistry collaborations. NervianoMS has also entrusted ChemDiv with supporting NervianoMS inventory with global logistic services. Financial terms were not disclosed.
"Our business relationship with ChemDiv is entering a phase of joint scientific endeavours with ambitious goals of innovation. The strengths of High-Throughput Screening and Combinatorial Chemistry at NervianoMS shall be complemented with ChemDiv's fully aligned synthetic productivity. NervianoMS is a world leader in oncology-focused R&D and one of a handful that performs HTS with a throughput of millions of data points per year. It is also one of only a couple in the world that conducts HTS campaigns running assays in parallel. Useful new chemical entities will be generated and tested with an efficiency level of the highest standard", said Francesco Colotta, VP of Oncology , NervianoMS.
"Collaboration with NervianoMS, a leader in area of oncology-focused drug discovery and development, further expands our capabilities to elaborate and accomplish custom synthesis projects to fulfill all requirements of our partners. Our alliance with Nerviano has already produced very promising results and we expect it to strengthen our competitive position," said Alexander Kiselyov, Executive VP of Research & Development, ChemDiv.
Other news from the department business & finance
These products might interest you
Most read news
More news from our other portals
Last viewed contents
Dharmacon's completion of first human genome-wide siRNA library signals new era in life-science research
Sequenom and NAFTNet to Conduct Fetal Rhesus D Study in Collaboration with Baylor College of Medicine
LFE Laboratorium für industrielle Forschung GmbH & Co. Entwicklungs KG - Bruchköbel, Germany
Andromeda Biotech Successfully Completes Patient Recruitment in Phase III Trials for DiaPep277 for Type 1 Diabetes
Bonnie Bassler and Martin Wikelski receive Max Planck Research Award - Scientists honoured for their pioneering research into the sensory perception of organisms
Stora Enso and Gasum to make renewable energy from wastewater in Sweden
LDC and HZI enter partnership for the discovery of new drugs against multi-resistant bacteria
New model could revolutionise the treatment of autoimmune disease as well as vaccine development - Paradigm shift in immunology: 'Adaptive Tolerance' balances autoimmune reaction
Generex Biotechnology and Pevion Biotech announce plans for immunotherapeutic vaccine collaboration
Successful Outcome from European Clinical Pharmacokinetic Study Comparing SUBA-Itraconazole with Sporanox - HalcyGen to begin Marketing Authorisation Application for Regulators in Europe
